You may find more results for this query on our sister sites: 360Dx and Precision Oncology News.
The firm said current adoption is robust, but enabling readout on NGS instruments this summer will be crucial to opening a much larger customer base.
The DNBSeq Tx system, several of which are already up and running at the China National GeneBank, can churn out up to 100,000 human genomes per year.
The Cambridge, Massachusetts-based firm also said it tacked on $3 million to its Series B financing round for a total of $30 million.
The company plans to offer four new products by the end of the year, including four targeted transcriptomic panels and IHC compatibility for Visium.
The company is currently building out its product portfolio to include additional cytokine profiling panels as well as tools for single-cell phosphoproteomics.
Researchers from the UK and Belgium identified more than 50 different cell states in the human thymus.
The partners will use Namocell's single-cell dispensing tool and Takara's Smart-seq technology to isolate and characterize HepaTx's hepatocyte-like cells.
S2 Genomics' Singulator platform combines enzymatic and mechanical disruption to produce suspensions of cells or nuclei for downstream applications.
Though 10x will phase out its linked reads technology, it plans to introduce targeted RNA-seq for Chromium and FFPE sample compatibility for Visium.
Researchers combined imaging mass spectrometry and genomic data to identify the cell types present in more than 480 breast cancer samples.
Single Technologies is working on a new sequencing platform with faster imaging and smaller flow cells that will harness existing chemistries.
Transcriptome profiles in ovarian cells from young and old non-human primates unearthed expression changes that coincided with flagging fertility in humans.
Researchers found sub-chromosomal aneuploidy, DNA damage pathway changes, and other somatic changes in breast cells from BRCA2 mutation carriers.
The firm's whole-genome amplification chemistry may help researchers better understand cancer heterogeneity, even between cells.
Researchers have identified immune cell gene expression signatures that could one day be developed into tests to predict response to treatment.
Blood and skin cell transcriptomes revealed a JAK-STAT signaling and human herpesvirus targets in an individual with refractory drug-induced hypersensitivity syndrome.
Researchers used Fluidigm's Hyperion Imaging System to quantify 35 protein biomarkers and examine the phenotypes and organization of single cells within breast tumors.
Illumina said the NextSeq 2000 and NextSeq 1000 reduce run costs by up to 50 percent, compared to the NextSeq 550 model, while increasing the data output.
Kindstar has also agreed to purchase Genesis systems for use by its scientists to monitor circulating tumor cells and for single-cell research.
The study, led by NYU researchers, provides a mathematical framework to find gene sets identifiable via both methods, revealing tissue architecture.
President Donald Trump announced the US would be leaving the World Health Organization, NBC News reports.
CDC head says a new analysis indicates earlier testing wouldn't have caught viral spread, NPR reports.
A study of Great Danes homes in on a genomic region linked to fearfulness.
In PLOS this week: gene expression and epigenetics of Indonesian populations, hookworm parasite secretome, and more.